Contrast Induced Nephropathy Clinical Trial
Official title:
Can Remote Ischaemic Preconditioning Reduce Contrast Induced Nephropathy in Patients Receiving Contrast for Computed Tomography?
Computated tomography (CT) is an invaluable medical resource for both physicians and
surgeons. Contrast media are an aid to improve the diagnostic yield of CT. While an
incredibly powerful means of imaging the human body, there are possible complications to the
use of contrast including a hypersensitive response and contract induced nephropathy (CIN).
The latter will typically occur 48-72 hours after administration.
One recent meta - analysis of serum creatinine levels following contrast enhanced CT found
6.4% of those undergoing this investigation developed CIN. Although typically transient, 1 %
had a persisting reduced renal function, with a small minority needing renal replacement
therapy (RRT). The development of CIN was influenced by co morbidities and by the amount of
contrast given.
The mechanism of injury to the kidney is not definitively established, but is thought most
likely due to hypoxia resulting from reduced blood flow, thereby giving rise to oxygen free
radicals causing direct damage to the kidney and also direct tubular damage.
Remote conditioning ischaemia has been hypothesized to be nephroprotective, whereby induced
transient ischaemia at another site could buffer the impact of the contrast medium's
effects. This was first demonstrated during cardiac angiograms, with those patients whom
received multiple balloon inflations in the coronary arteries were found to have a lower
incidence of CIN than those with fewer balloon inflations. Thus it could be hypothesised
that any ischaemia temporarily induced could be nephroprotective. This can be at a point of
extremity, rather than involving central organs, such as the arm, with ischaemia induced by
the use of a blood pressure cuff, inflated to above systolic blood pressure levels.
No studies have been found in the literature attempting to demonstrate this effect in
relation to contrast CT studies. Consequently, a randomised control clinical trial of
patients to assess the effectiveness of remote ischaemic preconditioning is proposed.
Study Hypothesis: That performing remote ischaemic preconditioning on those undergoing CTs
involving IV contrast is nephroprotective.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00842868 -
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
|
N/A | |
Completed |
NCT00634491 -
Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
|
Phase 2 | |
Terminated |
NCT00476619 -
Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
|
Phase 4 | |
Recruiting |
NCT03121053 -
Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
|
Phase 4 | |
Completed |
NCT02650336 -
Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
|
N/A | |
Terminated |
NCT00575419 -
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
|
Phase 1 | |
Not yet recruiting |
NCT00392405 -
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
|
Phase 2 | |
Completed |
NCT00292487 -
Patients With Renal Impairment Undergoing CT
|
Phase 4 | |
Recruiting |
NCT04982419 -
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
|
Phase 2/Phase 3 | |
Completed |
NCT00770614 -
Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
|
Phase 4 | |
Completed |
NCT01999517 -
Contrast Nephropathy and Nitrates
|
Phase 4 | |
Recruiting |
NCT00702728 -
Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention
|
Phase 3 | |
Completed |
NCT00531765 -
Sodium Bicarbonate in Preventing Contrast Induced Nephropathy
|
N/A | |
Completed |
NCT00639912 -
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
|
Phase 4 | |
Terminated |
NCT00494637 -
The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
|
N/A | |
Completed |
NCT02516072 -
Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy
|
N/A | |
Active, not recruiting |
NCT01402232 -
REduction of rIsk for Contrast Induced Nephropathy
|
||
Recruiting |
NCT02113540 -
Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
|
Phase 3 | |
Active, not recruiting |
NCT01456013 -
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
|
Phase 3 | |
Recruiting |
NCT01399203 -
Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention
|
N/A |